Prostate Cancer Clinical Trial
Linear Source Registry for Prostate Cancer
Ongoing follow up for subjects implanted with the Linear Source String for prostate cancer.
This registry is being conducted to provide long term analysis on the use of the linear Civastring source for prostate cancer. Prospective data collection will record and demonstrate biochemical response rates. Long term side effects and adverse events will be monitored.
Age > 18 years old
Plans to remain in care of enrolling physician for 5 years
> 5 years life expectancy
Signed informed consent
Enrolled within 6 weeks of implant or within 365 days of prior implant
Not willing or able to comply with protocol visit schedule
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
Chicago Illinois, 60559, United States
New York New York, 10016, United States
Norfolk Virginia, 23505, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.